MDCL

Medicine Man Technologies Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 5/16/2017
Contact Info
  • 4880 Havana Street
  • Suite 201 South
  • Denver, CO 80239

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001622879
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8742 - Management consulting services
Incorporated In: NV, USA
Year of Inc. 2014
Employees 14 a/o Jun 01, 2017
Company Officers/Contacts
Charley Haupt General Director
Brett Edward Roper CEO, Co-Founder
Andrew Johns Williams Co-Founder
Company Directors
Andrew Johns Williams Chairman
Paul Daniel Dickman
Brett Edward Roper
James Sylvester Toreson Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
B F Borgers CPA PC
5400 West Cedar Avenue
Lakewood, CO, 80226
United States
 
Securities Counsel
Andrew I Telsey, Esq.
12835 E. Arapahoe Road, Tower One,
Suite 803
Englewood, CO, 80112-55427
United States
 
Investor Relations Firm

Not Available
MDCL Security Details
Share Structure
Market Value1 $25,559,298 a/o Jun 27, 2017
Authorized Shares 90,000,000 a/o Mar 01, 2017
Outstanding Shares 18,454,367 a/o Jun 05, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,730,658 a/o Jun 05, 2017
Par Value 0.001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders
Shareholders of Record 2,675 a/o Jun 05, 2017
Short Selling Data
Short Interest 742 (-90.86%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security